pharmaceuticals - Publications - Faculty & Research - Harvard Business School

Filter Results: (1,252)

Filter Results: (1,252)

Show Results For

← Page 3 of 1,252 Results →

Research Summary

Marketing and Competition in Pharmaceutical Markets

In his research on pharmaceutical markets, Professor King explores how marketing and product differentiation affect competition among firms in the prescription market for anti-ulcer drugs. Four main results emerge from an analysis of antiulcer drug sales from 1977 to... View Details

April 1990
Case

International Pharmaceuticals Inc. (Abridged)

By: James E. Austin

Keywords: Pharmaceutical Industry

Find at Harvard

11 Oct 2011
Working Paper Summaries

US Healthcare Reform and the Pharmaceutical Industry

Keywords: by Arthur Daemmrich; Pharmaceutical; Pharmaceutical

February 1998 (Revised May 1998)
Case

Merck-Medco: Vertical Integration in the Pharmaceutical Industry

By: V. Kasturi Rangan and Marie Bell

Records the analyses and actions taken by Merck Pharmaceuticals in its acquisition of Medco, a channel intermediary (called "pharmacy benefit manager"). While many of its competitors seem to be faring poorly, Merck seems to have managed the Medco integration superbly. View Details

Keywords: Vertical Integration; Organizational Change and Adaptation; Competitive Strategy; Marketing Channels; Mergers and Acquisitions; Pharmaceutical Industry

August 2007
Teaching Note

Teva Pharmaceutical Industries, Ltd (TN)

By: Tarun Khanna and Krishna G. Palepu

Teaching note to 707441. View Details

Keywords: Growth and Development Strategy; Cost; Competitive Strategy; Adoption; Emerging Markets; Change; Multinational Firms and Management; Genetics; Pharmaceutical Industry; India

September 1988
Background Note

Note on the Pharmaceutical Industry

By: Regina E. Herzlinger

Keywords: Pharmaceutical Industry

Find at Harvard

January 1990 (Revised January 1993)
Teaching Note

International Pharmaceuticals Inc., Teaching Note

By: W. Carl Kester

Keywords: Pharmaceutical Industry

July 2002 (Revised December 2002)
Case

Phase Two: The Pharmaceutical Industry Responds to AIDS

By: Debora L. Spar

Describes how major pharmaceutical firms changed their strategy and pricing policies in the years 2000 to 2002 to respond to the growing AIDS epidemic in Africa. View Details

Keywords: International Finance; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa

September 2021 (Revised October 2022)
Supplement

Hester Pharmaceuticals (B): Securing Supply

By: Dante Roscini and John Masko

Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was... View Details

Keywords: COVID-19 Pandemic; Cost vs Benefits; Trade; Supply Chain; Global Strategy; Buildings and Facilities; Operations; Health Care and Treatment; Demand and Consumers; Global Range; Globalized Markets and Industries; Pharmaceutical Industry; Italy; China; United States; Germany

February 2003 (Revised April 2004)
Case

Pharmaceutical Industry, The: Challenges in the New Century

By: Stephen P. Bradley and James Weber

Provides a broad overview of the numerous internal and external forces that were driving change in the global pharmaceutical industry in 2003. These forces--including downward price pressures, political and social pressures, increased development costs, new... View Details

Keywords: Business Model; Change; Cost; Price; Globalization; Government and Politics; Brands and Branding; Industry Growth; Society; Competition; Consolidation; Technology; Pharmaceutical Industry

August 1994
Teaching Note

Yamanouchi Pharmaceutical Co., Ltd. TN

By: Robin Cooper and Robert S. Kaplan

Keywords: Pharmaceutical Industry

2006
Case

Takeda Pharmaceutical Company in 2007

By: Hirotaka Takeuchi

Keywords: Health; Pharmaceutical Industry

February 2002 (Revised March 2002)
Case

India's Intellectual Property Rights Regime and the Pharmaceutical Industry

In 1970, the Indian government significantly revised its patent law, Patents and Design Act of 1911. The 1911 act was enacted when India was a colony of Great Britain, and it was controversial because it led to the total dominance of India's pharmaceutical market by... View Details

Keywords: Patents; Pharmaceutical Industry; Great Britain; India

March 1993 (Revised May 1998)
Teaching Note

ImmuLogic Pharmaceutical Corporation (Series) TN

By: Josh Lerner

Teaching Note for (9-293-066--071) and (9-293-087). View Details

Keywords: Pharmaceutical Industry

January 2006 (Revised May 2007)
Supplement

Endo Pharmaceuticals (D): Hatch-Waxman Change

By: Richard G. Hamermesh and Brian DeLacey

Keywords: Change; Pharmaceutical Industry

January 2006 (Revised May 2007)
Supplement

Endo Pharmaceuticals (B): Merger Decision

By: Richard G. Hamermesh and Brian DeLacey

Keywords: Mergers and Acquisitions; Pharmaceutical Industry

30 Mar 2012
HBS Seminar

Matthew W. Emmens, Executive Chairman,Vertex Pharmaceuticals

October 1992 (Revised April 1993)
Supplement

ImmuLogic Pharmaceutical Corporation (B4): Phillip Gross

By: Josh Lerner

Supplements the (A) case. View Details

Keywords: Pharmaceutical Industry

June 1990
Teaching Note

International Pharmaceuticals Inc. (Abridged), Teaching Note

By: James E. Austin and Tomas Otto Kohn

Keywords: Pharmaceutical Industry

1995
Chapter

Pharmaceutical Companies and Health Care Reform

By: Arthur A. Daemmrich

Keywords: Health Care and Treatment; Governing Rules, Regulations, and Reforms; Government and Politics; Policy; Business and Government Relations; Pharmaceutical Industry

←
3
4
…
62
63
→